_256_384.jpg)
News | September 01, 2021
Pharma tops India’s exports from SEZs
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
Essential medicines were made available to more than 150 countries around the world during the pandemic
Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Approval strengthens the company’s growing international anti-infective portfolio
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Subscribe To Our Newsletter & Stay Updated
